Effect of eplerenone in acute heart failure using a win ratio approach

Clin Res Cardiol. 2024 Nov 20. doi: 10.1007/s00392-024-02578-0. Online ahead of print.

Masatake Kobayashi^{1

2}, Akira Yamashina¹, Kazuhiro Satomi¹, Ayako Tezuka¹, Kevin Duarte², Shin Ito³, Masanori Asakura⁴, Masafumi Kitakaze^{5

6

7}, Nicolas Girerd²

¹ Department of Cardiology, Tokyo Medical University, Tokyo, Japan.
² Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique 1433, Inserm U1116, CHRU de Nancy and F-CRIN INI-CRCT, Nancy, France.
³ Department of Clinical Research and Development, National Cerebral and Cardiovascular Center, Osaka, Japan.
⁴ Department of Cardiovascular and Renal Medicine, Hyogo Medical University, Hyogo, Japan.
⁵ Department of Clinical Research and Development, National Cerebral and Cardiovascular Center, Osaka, Japan. kitakaze@zf6.so-net.ne.jp.
⁶ Hanwa Memorial Hospital, Osaka, Japan. kitakaze@zf6.so-net.ne.jp.
⁷ Hanwa Daini Senboku Hospital, 3176 Fukaikitamach, i, Naka-Ku Sakai City, Osaka, Japan. kitakaze@zf6.so-net.ne.jp.

No abstract available

Keywords: Acute heart failure; Eplerenone; Mineralocorticoid receptor antagonist; Prognosis; Win ratio analysis.

Publication types